Log in to save to my catalogue

Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccine...

Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccine...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62da98c2d5274e8d901e89c3f4c4faee

Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Other authors have reported that in natural infection anti-Spike RBD IgA antibodies showed to be the major responsible of the neutralizing ability in early stages.2 Regarding the cellular response, CD4+ but not CD8+ T-cell activities against SARS-CoV-2 spike peptide pool (Supporting information Figure S2A) remained high at late-time points in naïve...

Alternative Titles

Full title

Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_62da98c2d5274e8d901e89c3f4c4faee

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62da98c2d5274e8d901e89c3f4c4faee

Other Identifiers

ISSN

2001-1326

E-ISSN

2001-1326

DOI

10.1002/ctm2.869

How to access this item